Xencor Recap Settlement's $2.4M Balance Approved In Del.
Class attorneys secured a final settlement Tuesday in what was a potentially damaging pair of Delaware Chancery Court claims against biopharmaceutical company Xencor Inc. arising from a flawed recapitalization and other...To view the full article, register now.
Already a subscriber? Click here to view full article